FIELD: chemistry; pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical chemistry, specifically to synthesis of 2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide (fonturacetam) used as a nootropic. Method of producing fonturacetam from phenibut by alkylation thereof with 2-haloacetamide is characterized by that the process is carried out in water, in one chemical step, combining alkylation and cyclisation, in the presence of a weak base – an organic amine of general formula R1R2R3N, where R1, R2, R3 are alkyl, alkylidene groups, both separate from each other and forming closed cycle(s), including containing heteroatoms O, S, N.
EFFECT: safe and processable single-step method of producing the desired compound using available raw material and water as a solvent, while maintaining an acceptable output of the product.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING 4-SUBSTITUTED 2-[2-OXO-1-PYRROLIDINYL] ACETAMIDE | 2016 |
|
RU2629117C1 |
| NOVEL COMPOSITIONS OF N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE | 2018 |
|
RU2699669C1 |
| METHOD OF PREPARING 3-PHENYL-4-AMINOBUTYRIC ACID OR 3-PHENYL-4-AMINOBUTYRIC ACID CHLOROHYDRATE | 2000 |
|
RU2166497C1 |
| N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE NEW COMPOSITION | 2017 |
|
RU2696277C2 |
| NOVEL COMPOSITIONS OF N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE FOR TREATING AND PREVENTING OBESITY | 2019 |
|
RU2732245C1 |
| DERIVATIVES OF 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B]-INDOL-1-ACETAMIDE, THEIR SYNTHESIS AND APPLICATION IN THERAPY | 1998 |
|
RU2197490C2 |
| DERIVATIVES OF 2-OXO-1-PYRROLIDINE, METHOD FOR THEIR PREPARING AND USING | 2001 |
|
RU2291860C2 |
| DERIVATIVES OF 4-PYRROLIDINE PHENYL BENZOLE ETHER | 2003 |
|
RU2336268C2 |
| SUBSTITUTED N-(INDOLE-2-CARBONYL)-BETA-ALANYLAMIDES AND THEIR DERIVATIVES, METHOD OF TREATING GLYCOGENPHOSPHORYLAZO-DEPENDENT DISEASES, METHOD FOR PREVENTING ISCHEMIC MYOCARDIUM DAMAGES, AND PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2159613C2 |
| METHOD OF SYNTHESIS OF THE SUBSTITUTED BENZOFURAN DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2098415C1 |
